Ohwia caudata inhibits doxorubicin‐induced cardiotoxicity by regulating mitochondrial dynamics via the IGF‐IIR/p‐Drp1/PARP signaling pathway
Biotechnology and Applied Biochemistry · 2024
DOI: 10.1002/bab.2620 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Applied Biochemistry, 2024. Verfasst von Jhong-Kuei Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chinese Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan. Hauptthemen laut MEDLINE: Doxorubicin, Signal Transduction, Mitochondrial Dynamics, Dynamins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation.
Abstract (Originalsprache)
The most effective drug, doxorubicin (DOX), is widely used worldwide for clinical application as an anticancer drug. DOX‐induced cytotoxicity is characterized by mitochondrial dysfunction. There is no alternative treatment against DOX‐induced cardiac damage despite intensive research in the present decades. Ohwia caudata has emerged as a potential herbal remedy that prevents from DOX‐induced cytotoxicity owing to its pharmacological action of sustaining mitochondrial dynamics by attenuating oxidative stress and inducing cellular longevity. However, its underlying mechanisms are unknown. The novel treatment provided here depends on new evidence from DOX‐treated H9c2 cells, which significantly enhanced insulin‐like growth factor (IGF) II receptor (IGF‐IIR) pathways that activated calcineurin and phosphorylated dynamin‐related protein 1 (p‐Drp1) at ser616 (p‐Drp1[ser616]); cells undergo apoptosis due to these factors, which translocate to mitochondria and disrupt their function and integrity, and in terms of herbal medicine treatment, which significantly blocked these phenomena. Thus, our findings indicate that maintaining integrity of mitochondria is an essential element in lowering DOX‐induced cytotoxicity, which further emphasizes that our herbal medicine can successfully block IGF‐IIR pathways and could potentially act as an alternative mechanism in terms of cardioprotective against doxorubicin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chinese Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.
- Integration Center of Traditional Chinese and Modern Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.
- Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan.
- Cardiovascular and Mitochondrial Related Disease Research Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.
- Department of Research and Innovation, Institute of Biotechnology, Saveetha School of Engineering (SSE), Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, India.
- Department of Biotechnology, Bharathiar University, Coimbatore, India.
ORCID-Profile: Chih-Yang Huang
Förderung
- Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Zitieren
APA
Chen, J. K., Ramesh, S., Islam, M. N., Shibu, M. A., Kuo, C. H., Hsieh, D. J., Lin, S. Z., Kuo, W. W., Huang, C. Y., & Ho, T. J. (2024). Ohwia caudata inhibits doxorubicin‐induced cardiotoxicity by regulating mitochondrial dynamics via the IGF‐IIR/p‐Drp1/PARP signaling pathway. Biotechnology and Applied Biochemistry. https://doi.org/10.1002/bab.2620
Vancouver
Chen JK, Ramesh S, Islam MN, Shibu MA, Kuo CH, Hsieh DJ, et al. Ohwia caudata inhibits doxorubicin‐induced cardiotoxicity by regulating mitochondrial dynamics via the IGF‐IIR/p‐Drp1/PARP signaling pathway. Biotechnology and Applied Biochemistry. 2024. doi:10.1002/bab.2620
BibTeX
@article{Chen2024,
author = {Chen, Jhong-Kuei and Ramesh, Samiraj and Islam, Md Nazmul and Shibu, Marthandam Asokan and Kuo, Chia-Hua and Hsieh, Dennis Jine-Yuan and Lin, Shinn-Zong and Kuo, Wei-Wen and Huang, Chih-Yang and Ho, Tsung-Jung},
title = {Ohwia caudata inhibits doxorubicin‐induced cardiotoxicity by regulating mitochondrial dynamics via the IGF‐IIR/p‐Drp1/PARP signaling pathway},
journal = {Biotechnology and Applied Biochemistry},
year = {2024},
doi = {10.1002/bab.2620}
}
EUVIMED